Table 1.
Demographic, illness severity and treatment data
| Variable | N = 110 |
|---|---|
| Age, years, mean (SD) |
50.9 (16.9) |
| Gender, male/female, n (%) |
70 (63.6)/40 (36.4) |
| Height, m, mean (SD) |
1.71 (0.09) |
| Weight, kg, mean (SD) |
80.9 (22.4) |
| Body surface area, m2, mean (SD) |
1.92 (0.24) |
| APACHE II, mean (SD) |
16.1 (6.20) |
| Modified SOFA, median [IQR] |
3 [2-5] |
| Admission type, n (%) |
|
| - Elective |
15 (13.6) |
| - Emergency |
33 (30.0) |
| - Surgical emergency |
37 (33.6) |
| - Trauma |
25 (22.7) |
| Mechanical ventilation, n (%) (n = 108) |
63 (57.3) |
| Intravenous contrast administration, n (%) (n = 109) |
30 (27.3) |
| Frusemide administration, n (%) |
13 (11.8) |
| Mannitol administration, n (%) |
4 (3.6) |
| Vasopressors, n (%) |
33 (30.0) |
| Systemic inflammatory response syndrome, n (%) |
95 (86.4) |
| Plasma creatinine concentration, μmol/L, mean (SD) |
68.5 (21.8) |
| Plasma creatinine concentration + 24 hrs, μmol/L, mean (SD) (n = 80) |
63.0 (19.6) |
| ICU length of stay, days, median [IQR] |
4 [2-10] |
| ICU mortality, n (%) | 11 (10) |
APACHE-Acute physiology and chronic health evaluation, ICU-Intensive care unit, SOFA-sequential organ failure assessment.